EU says won't take up option to buy 100 million extra COVID vaccines from AstraZeneca

BRUSSELS, April 22 (Reuters) - The European Commission said on Thursday it would not take up an option to buy 100 million additional doses of AstraZeneca's (AZN.L) COVID-19 vaccine which is included in the current supply contract the EU has with the company.

A spokesman told a news conference that the deadline to exercise the option had already expired and the EU did not plan to take it up, confirming a Reuters report from Wednesday.

The Commission has ordered 300 million doses from AstraZeneca as part of a contract that included 400 million doses, of which 100 million was optional.

Reporting by Francesco Guarascio @fraguarascio Editing by Gareth Jones

Our Standards: The Thomson Reuters Trust Principles.